Series B funding round for NextPoint Therapeutics raising $43M in February 2024
Series B funding round for NextPoint Therapeutics raising $43M in February 2024
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Angel | Gordon Freeman |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$123M
Top Valuation
-
NextPoint Therapeutics raised $43M in a Series B round.
The round was announced on 02/01/24.
The round was led by Jacob Vogelstein.